Complications of anti-androgenic hormone therapy for prostate cancer

被引：1
作者：
Ziouziou, Imad [1 ]
Karmouni, Tariq [1 ]
El Khader, Khalid [1 ]
Koutani, Abdellatif [1 ]
Andaloussi, Ahmed Iben Attya [1 ]
机构：
[1] CHU Ibn Sina, Serv Urol B, Rabat, Morocco
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2014年 / 8卷 / 3-4期
关键词：
DEPRIVATION THERAPY; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; INSULIN-RESISTANCE; MEN; RISK; TESTOSTERONE; RADIOTHERAPY; ASSOCIATION; SUPPRESSION;
D O I：
10.5489/cuaj.1608
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E159 / E162
页数：4
相关论文
共 34 条
  • [1] Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States
    Beebe-Dimmer, Jennifer L.
    Cetin, Karynsa
    Shahinian, Vahakn
    Morgenstern, Hal
    Yee, Cecilia
    Schwartz, Kendra L.
    Acquavella, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (01) : 70 - 78
  • [2] Androgen deprivation therapy for prostate cancer: Implications for cardiometabolic clinical care
    Collins, L.
    Mohammed, N.
    Ahmad, T.
    Basaria, S.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (03) : 332 - 339
  • [3] Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
    Crook, Juanita M.
    O'Callaghan, Christopher J.
    Duncan, Graeme
    Dearnaley, David P.
    Higano, Celestia S.
    Horwitz, Eric M.
    Frymire, Eliot
    Malone, Shawn
    Chin, Joseph
    Nabid, Abdenour
    Warde, Padraig
    Corbett, Thomas
    Angyalfi, Steve
    Goldenberg, S. Larry
    Gospodarowicz, Mary K.
    Saad, Fred
    Logue, John P.
    Hall, Emma
    Schellhammer, Paul F.
    Ding, Keyue
    Klotz, Laurence
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10) : 895 - 903
  • [4] Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions
    D'Amico, Anthony V.
    Denham, James W.
    Crook, Juanita
    Chen, Ming-Hui
    Goldhaber, Samuel Z.
    Lamb, David S.
    Joseph, David
    Tai, Keen-Hun
    Malone, Shawn
    Ludgate, Charles
    Steigler, Allison
    Kantoff, Philip W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2420 - 2425
  • [5] Circumstances of prescription of hormone therapy for patients with prostate cancer
    de la Taille, A.
    [J]. PROGRES EN UROLOGIE, 2009, 19 (05): : 313 - 320
  • [6] Osteoporosis in men
    Ebeling, Peter R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) : 1474 - 1482
  • [7] Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    Freedland, SJ
    Humphreys, EB
    Mangold, LA
    Eisenberger, M
    Dorey, FJ
    Walsh, PC
    Partin, AW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04): : 433 - 439
  • [8] Low testosterone levels are common and associated with insulin resistance in men with diabetes
    Grossmann, Mathis
    Thomas, Merlin C.
    Panagiotopoulos, Sianna
    Sharpe, Ken
    MacIsaac, Richard J.
    Clarke, Sophie
    Zajac, Jeffrey D.
    Jerums, George
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) : 1834 - 1840
  • [9] Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
    Grossmann, Mathis
    Zajac, Jeffrey D.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 74 (03) : 289 - 293
  • [10] Testosterone and type 2 diabetes
    Grossmann, Mathis
    Gianatti, Emily J.
    Zajac, Jeffrey D.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (03) : 247 - 256
1234